Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
Clinical trial NCT05131711 · UNKNOWN
Trial details
- NCT number
- NCT05131711
- Sponsor
- Beijing Tiantan Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2022-11-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.